Livent (LTHM) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.
The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this supplier of performance lithium compounds, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.
Consensus earnings estimates for the next quarter and full year have moved considerably higher for Livent, as there has been strong agreement among the covering analysts in raising estimates.
Current-Quarter Estimate Revisions
The company is expected to earn $0.39 per share for the current quarter, which represents a year-over-year change of +1200%.
Over the last 30 days, the Zacks Consensus Estimate for Livent has increased 18.16% because three estimates have moved higher compared to no negative revisions.
Current-Year Estimate Revisions
The company is expected to earn $1.38 per share for the full year, which represents a change of +666.67% from the prior-year number.
In terms of estimate revisions, the trend for the current year also appears quite encouraging for Livent. Over the past month, four estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 12.15%.
Favorable Zacks Rank
The promising estimate revisions have helped Livent earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.
While strong estimate revisions for Livent have attracted decent investments and pushed the stock 36.8% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Livent Corporation (LTHM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research